|
DAG1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.848400E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.27920000000537E-05 |
| Normal-vs-Stage2 |
3.616700E-03 |
| Normal-vs-Stage3 |
2.770800E-01 |
| Normal-vs-Stage4 |
6.440200E-02 |
| Stage1-vs-Stage2 |
7.677000E-01 |
| Stage1-vs-Stage3 |
4.036600E-01 |
| Stage1-vs-Stage4 |
3.819000E-01 |
| Stage2-vs-Stage3 |
3.649000E-01 |
| Stage2-vs-Stage4 |
6.031000E-01 |
| Stage3-vs-Stage4 |
3.189800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.988500E-04 |
| Normal-vs-AfricanAmerican |
4.814800E-04 |
| Normal-vs-Asian |
6.058900E-03 |
| Caucasian-vs-AfricanAmerican |
5.502800E-01 |
| Caucasian-vs-Asian |
4.634200E-01 |
| AfricanAmerican-vs-Asian |
5.250800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.63770000003194E-06 |
| Normal-vs-Female |
7.449000E-01 |
| Male-vs-Female |
4.32160000000126E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.677890E-03 |
| Normal-vs-Extreme_Weight |
1.964560E-04 |
| Normal-vs-Obese |
2.252300E-02 |
| Normal-vs-Extreme_Obese |
1.267820E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.030600E-01 |
| Normal_Weight-vs-Obese |
3.557000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.248400E-01 |
| Extreme_Weight-vs-Obese |
2.023400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.355400E-01 |
| Obese-vs-Extreme_Obese |
7.465800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.391800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.256100E-02 |
| Normal-vs-Age(61-80Yrs) |
1.72600999999162E-05 |
| Normal-vs-Age(81-100Yrs) |
1.582440E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.949800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.582000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.256500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.450400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.925710E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.200200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.802700E-03 |
| Normal-VS-Type2 PRCC |
7.2853999999456E-07 |
| Normal-VS-KIRP CIMP |
4.909200E-01 |
| Normal-VS-Unclassified PRCC |
6.816000E-02 |
| Type1 PRCC-VS-Type2 PRCC |
9.261700E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.593970E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.167200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.919800E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.701900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.942370E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.86508999999724E-05 |
| Normal-vs-N1 |
2.766500E-02 |
| Normal-vs-N2 |
9.437600E-01 |
| N0-vs-N1 |
4.249400E-01 |
| N0-vs-N2 |
4.344000E-01 |
| N1-vs-N2 |
3.355000E-01 |
|
|
